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Metabolic diseaseThe incidence of metabolic disease, including type 2 diabetes and obesity, has increased to epidemic levels in re-
cent years. A growing body of evidence suggests that the intrauterine environment plays a key role in the devel-
opment of metabolic disease in offspring. Among other perturbations in early life, alteration in the provision of
nutrients has profound and lasting effects on the long term health and well being of offspring. Rodent and
non-human primatemodels provide ameans to understand the underlyingmechanisms of this programming ef-
fect. These differentmodels demonstrate converging effects of amaternal high fat diet on insulin and glucoseme-
tabolism, energy balance, cardiovascular function and adiposity in offspring. Furthermore, evidence suggests that
the early life environment can result in epigenetic changes that set the stage for alterations in key pathways of
metabolism that lead to type 2 diabetes or obesity. Identifying and understanding the causal factors responsible
for thismetabolic dysregulation is vital to curtailing these epidemics. This article is part of a Special Issue entitled:
Modulation of Adipose Tissue in Health and Disease.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The thrifty phenotype hypothesis of Hales and Barker proposes that
poor nutrition in early life results in poor fetal growth and increased
susceptibility to type 2 diabetes and the metabolic syndrome [1,2].
Evidence from epidemiological studies aswell as animalmodels suggest
that the intrauterine environment plays a role in the development
of obesity and metabolic disorders. These studies demonstrate that
suboptimal maternal nutrition, whether under-nutrition or over-
nutrition, has negative effects on the offspring [3–9]. Fetal development
is dependent on maternal supply of nutrients. Thus, alterations in ma-
ternal metabolism would expose the fetus to a perturbed intrauterine
milieu that may predispose offspring to metabolic disease in later life.
This concept, known as developmental origins of health and disease
(DOHaD) states that a stimulus or insult at a critical period of develop-
mental plasticity in early life causes disruptions in normal growth
and development, as a result one genotype can give rise to different
phenotypes in response to different environmental conditions duringion of Adipose Tissue in Health
ric Endocrinology, 1991Marcus
emistry, Albert Einstein College
Y 10461, USA. Tel.: +1 718 430
ights reserved.development [10–12]. Furthermore, a mismatch between the pre- and
postnatal environment may result in inappropriate adaptations and
subsequentmetabolic disease, also known as the predictive adaptive re-
sponse (PAR) hypothesis [13]. In animal models there is a commonality
in the phenotypic outcomes of offspring frommothers exposed to either
under- or over-nutrition. This phenotype is usually associatedwith poor
fetal growth,mediated by the insulin growth factor axis, followedby the
development of metabolic disease later in life [14–16].
Although initial studies on the thrifty phenotype hypothesis focused
predominantly on the effects of maternal under-nutrition such as a diet
low in protein or calories [17–19], recent studies have sought to inves-
tigate the effects of maternal over-nutrition. A maternal high fat diet
(HFD) is more reﬂective of the dietary habits in western society. A ma-
ternal HFD can alter the development of various organs and thus the off-
spring become more susceptible to disease in later life. It has been
shown that not only are dietary exposures during pregnancy important
in mediating this disease susceptibility but also the timing of this expo-
sure during development [20,21]. Thus, since the fetus or neonate is un-
dergoing rapid cell division, tissues may be affected differently by the
same exposure depending on the timing of the insult.
Animal models provide an invaluable tool to study the underlying
mechanisms of developmental programming. Rodent and non-human
primates (NHP) are mammalian systems with similar embryology,
anatomy and physiology to humans. Utilization of these systems has
led to a greater understanding of the underlying mechanisms of
DOHaD. Rodents are advantageous to study due to practical and eco-
nomic reasons and the effect of manipulation of offspring can be seen
within a short time. In contrast, NHPs are non-litter bearing animals
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advantage of requiring considerable resources to maintain and have a
lengthy gestation and lifespan.
The phenotypic outcome of the offspring exposed to amaternal HFD
during development varies based on the species, diet composition,
timing and length of HFD consumption. In addition, maternal factors
such as obesity, the presence of glucose intolerance, diabetes and insulin
resistance may contribute independently of the diet to the phenotype
observed in the offspring. Thus, most of the methods used to develop
animals models of developmental programming can be confounded
by the presence ofmore than one insult. Similarly, other dietary compo-
nents such as protein, carbohydrates andmicronutrients have to be con-
sidered. To be able tomaintain the same caloric content, changes in one
component may result in the increase or reduction of another [22].
Prior DOHaD reviews [23] have either focused on maternal over-
nutrition (combining studies on HFD, high sugar or junk food diet)
[24], maternal obesity [25,26] or “only” one outcome i.e., howmaternal
HFD causes epigenetic changes [27]. This review focuses on animal
models that demonstrate offspring effects resulting from exposure to a
maternal HFD irrespective of maternal obesity. The PubMed database
was searched for articles published between 1995 and 2013 using the
key terms high fat in utero and maternal high fat programming. Articles
obtained from this search are discussed in this review. A brief summary
of all the knownmetabolic andmolecular changes that have been iden-
tiﬁed from animal models of a HFD in utero are summarized in Table 1.
2. Mouse
Usingmouse as amodel, several studies have demonstrated adverse
metabolic outcomes in offspring exposed to a maternal HFD. Included
aremodels of poor fetal growth and adversemetabolic events including
liver dysfunction, high blood pressure, alterations in bone structure and
effects on behavior and or emotional health.
In the mother, HFD has been shown to alter maternal food intake,
substrate utilization, body composition, glucose and lipid metabolism,
leptin levels and placenta nutrient transport [26,28–31]. Hartil et al.
have demonstrated that different metabolic outcomes in offspring
such as catch up growth, increased adiposity and impaired glucose tol-
erance and insulin sensitivity was associated with maternal metabolic
dysfunction illustrated by increased serum levels of non-esteriﬁed
fatty acids (NEFA) and lactate accompanied by increased expression of
peroxisome proliferator activated receptor γ coactivator-1β (PGC1β)
mRNA in liver [28]. In contrast, glucose transporter 4 heterozygous
(GLUT4+/−) females (a model of insulin resistance) consuming the
same diet display enhanced lipid clearance and no signiﬁcant alter-
ations in expression of genes of glucose or lipid metabolism in their
liver, suggesting that the mother's ability to adequately utilize different
diets may play a role in the programming effects seen in the offspring.
In addition to acute alteration in maternal substrate utilization,
chronic high fat feeding leading to maternal obesity is another factor
that can have adverse effects on the offspring. This is cause for concern
because of the signiﬁcant increase of obesity in women of child-bearing
age [32]. Animal models that have investigated the effect of maternal
obesity on the offspring have reported hyperphagia, adiposity, hyper-
tension and insulin resistance in the offspring [33–35] dyslipidemia
and hepatic steatosis [33]. Krasnow et al. has shown that switching
obese mothers to a low fat diet (LFD) for a subsequent pregnancy can
minimize the metabolic effects seen by the HFD/maternal obesity in
C57BL/6 mice [36]. Similar ﬁndings have been observed by introducing
the HFD shortly before mating, without changing maternal body com-
position [26,28,37,38]. These data suggest a maternal HFD has adverse
effects on the offspring, whether or not maternal obesity is present
and that it is possible to reverse these effects by switching the diet.
HFD diet during pregnancy has been shown to alter the placenta
leading to either small or large fetuses [29,39]. While some studies re-
port HFD offspring being born smaller than controls [40], others reportthe opposite. The differences may be due to different dietary compo-
nents, fat source or the strain of mice used. Despite being born small,
some studies report catch up growth in the HFD growth restricted off-
spring, this in itself is also associatedwith the development ofmetabolic
disease [28]. Pregnancies associatedwith large fetuses are accompanied
by upregulation of placental nutrient transport (glucose and neutral
amino acids) compared to offspringwhosemothers consumed a control
diet [29]. HFD increased glucose transporter 1 (GLUT1) and sodium
coupled neutral amino acid transporter 2 (SNAT2) protein expression
in trophoblast microvillus plasma membranes isolated from the pla-
centas of HFD animals at embryonic day 18.5 [29]. These data suggest
nutrients are the most important factors during development.
Decreased fetal bodyweight has been associatedwith early catch up
growth. Using dams thatwereWTor heterozygous for GLUT4 (G4+/−)
expression, a decrease in birthweightwas observed in offspring born to
both genotypic mothers that consumed the HFD irrespective of geno-
type. At embryonic day 18.5 these offspring had decreased fetal weight
and crown rump length [40]. Only the WT male offspring born to WT
mothers consuming a HFD demonstrated early life catch up growth
(CUG) and increased adiposity accompanied by impaired glucose toler-
ance and insulin sensitivity despite their being weaned to a LFD. Fur-
thermore, these offspring had increased serum glucose and PAI-1 and
decreased adiponectin [40]. Conversely, WT male offspring born to
GLUT4+/−mothers that consumed a HFDwere protected from preco-
cious manifestation of these characteristics of the Metabolic Syndrome
[28]. These data suggest that although offspring exposed to a maternal
HFD are born small, thismaynot always translate to a negativemetabol-
ic outcome. Early life CUG appears to have a negative impact on the off-
spring. Furthermore, the mother's ability to utilize the HFD appears to
be a determining factor in whether or not the offspring is susceptible
to metabolic disease.
Metabolic Syndrome, a cluster of disorders that increase the risk for
diabetes and cardiovascular disease, is the common phenotype seen in
models of DOHaD. Offspring exposed to a maternal HFD in utero and/
or postnatally developed manifestations of the Metabolic Syndrome,
such as insulin resistance, increased liver mass and triglyceride content,
hepatic steatosis, increased visceral fat mass and adipocyte hypertrophy
but not central leptin resistance [30,41]. These changes are accompa-
nied by increased serum concentrations of tumor necrosis factor α
(TNFα) and interleukin 1β (IL-1β) [30]. These data suggest serum fac-
tors may play a role in the mechanisms involved in the development
of the Metabolic Syndrome in HFD exposed offspring.
Changes in blood pressure (increase in systolic blood pressure), an-
other feature of the Metabolic Syndrome, were seen in offspring ex-
posed to a maternal HFD [33]. Similarly, exposing G4+/− mice to a
HFD in utero was associated with a premature increase in systolic
blood pressure as early as 13 weeks of age [40]. These data demonstrate
that a HFD during pregnancy as well as a heterozygous deletion of
GLUT4 increases offspring susceptibility to increased systolic blood
pressure.
Similar to changes in blood pressure, alterations in the offspring
plasma lipids are seen in response to a maternal HFD. In a study by
Elahi et al., plasma lipids were increased in a sexually dimorphic man-
ner. In female offspring exposed to either maternal control (C) or HFD
and weaned to a HFD have increased cholesterol levels whereas only
males exposed to a maternal HFD in utero have increased cholesterol
[33]. Changes in offspring lipid levels have also been seen after the expo-
sure to different dietary fats, speciﬁcally exposure to saturated fatty
acids (SFA). The group in which the mothers and offspring were ex-
posed to SFA had the highest plasma concentrations of total cholesterol
and low-density lipoprotein (LDL) cholesterol while the polyunsaturat-
ed fatty acid exposed group had the lowest levels of total cholesterol
and LDL cholesterol compared to the other groups. The plasma high-
density lipoprotein (HDL) cholesterol concentrations were signiﬁcantly
higher in the animals exposed to polyunsaturated fatty acids (PUFA) in
utero andweaned to SFA [42]. This demonstrates amaternal HFD affects
Table 1
Effect of a maternal high fat diet on offspring phenotype. Abbreviations: (G: gestation, L: lactation).
Animal Duration of maternal HFD Composition Effect (offspring) Organ affected
(offspring)
Ref
Mouse 2 weeks prior to mating, during G and L 36% of calories from fat Decreased fetal growth and birth weight, increased
expression of hepatic lipogenic genes
Liver [28]
4, 12 or 23 weeks prior to mating 60% of calories from fat No effect on hepatic inﬂammation or expression of genes
involved in lipid metabolism
– [36]
8 weeks prior to mating, during G and L 32% of calories from fat Increased fetal weight and placental GLUT1 and SNAT2
mRNA
Placenta [29]
8 weeks prior to mating, during G 60% of calories from fat Type 2 diabetes in F1 and F2, higher β-cell mass in F1,
lower β-cell mass in F2
Pancreas [51]
During P and L until 3 months 49% of calories from fat Insulin resistance, increased hepatic triglycerides,
hepatic steatosis
Liver [41]
1 week prior to mating, during G and L 35% of calories from fat Metabolic syndrome, hepatic lipid accumulation,
increased hepatic JNK phosphorylation
Liver [30]
4 weeks prior to conception during G and L 45% of calories from fat Reduced mitochondrial function, increased hepatic
lipogenesis, oxidative stress, changes the expression of
inﬂammatory genes
Liver [47]
During G, L, G and L 49% of calories from fat Insulin resistance, increased expression of hepatic
lipogenic genes
Liver [37]
6 weeks prior to mating, during G and L 53% of calories from fat Increased birth weight, increased protein levels in fatty
acid oxidation, altered hepatic microRNA
Liver [48,49]
6 weeks prior to mating, during G and L 18% fat (w/w) Hypertension, hepatic steatosis Liver [33]
During G and L 18% fat (w/w) Effects on bone quantity and quality Bone [52]
3 weeks prior to mating, during G and L 60% of calories from fat Increased anxiety behavior, molecular changes in the
hippocampus
Brain [53]
During G and L 20% fat (PUFA or SFA) SFA increased total plasma cholesterol and low density
lipoprotein cholesterol
– [42]
During G and L 20%w/w(PUFA or SFA) Reduced hepatic and heart DHA content Liver, Heart [43]
4 weeks prior to mating 62% of calories from fat Increased blood pressure and body weight, altered
histone modiﬁcation of ADIPOQ promoter
Adipose [95]
12 weeks prior to mating, during G and L 60% of calories from fat Decrease in global methylation in brain Brain [96]
During G 45% of calories from fat Increased birth weight and glucose level, altered histone
modiﬁcation of PCK1 gene
Liver [98]
2 weeks prior to mating, during G and L 21% fat (w/w) Altered vascular function and CpG methylation of FADS2
promoter
Liver, aorta [99,100]
4 weeks prior to mating, during G and L 45% of calories from fat Reduced insulin sensitivity, altered growth hormone GH
axis, increased body length, altered expression of
paternally imprinted genes in F3
Liver, Brain [31,103]
Rat During G and L 40% of calories from fat No difference in birth weight – [38]
From postnatal day 24, during G and L 60% of calories from fat Increased body weight, glucose and insulin levels, and
insulin secretion
Pancreas [54]
From pregnancy to postnatal day 10 21% fat (w/w) Increased serum insulin and leptin, increased blood
pressure and left ventricular wall thickness
Left ventricle [62]
4 weeks prior to mating, during G and L 60% of calories from fat Increased adiposity and serum leptin – [57]
10 days prior to mating, during G and L 33% fat (w/w) Reduced serum DHA – [64]
15 days prior to mating, during G and L 40% (w/w) Decreased hepatic mtDNA copy number and PGC1α
mRNA expression
Liver [59]
6 weeks prior to mating, during G 35% of calories from fat Increased serum leptin, body weight and alterations in
food motivated behavior
– [60]
10 days prior to mating, during G and L 26% of calories from fat Increased blood pressure, altered aortic structure and
renal function, insulin resistance, lower heart rate,
endothelial dysfunction, and altered vascular fatty acid
content
Aorta [58,65–70]
6 weeks prior to mating until the end of
weaning
40% of calories from fat Increased body weight, serum leptin and insulin, and
reduced hypothalamic leptin-dependent STAT3
phosphorylation
Brain [71]
11 weeks prior to mating (from postnatal 23), G 60% of calories from fat Increased serum leptin and insulin, and expression of
hypothalamic appetite-regulating genes
Brain [72]
Started embryonic day 6 50% of calories from fat Precocious puberty, increased proliferation of
neuroepithelial and neuronal precursor cells
Brain [73]
8 weeks prior to mating, during G and L 29% of calories from fat Increased bodyweight, blood glucose and leptin, reduced
phospho-STAT3 and SOCS3 expression in the arcuate
nucleus
Brain [55]
From gestational day 2 60% of calories from fat Increased body weight and serum leptin, and reduced
phosphorylation of STAT3 in the arcuate nucleus
Brain [56]
Deﬁned periods of G and L 40% of calories from fat Increased serum glucose and reduced pancreatic
glucokinase mRNA
Pancreas [74]
During G, L or G and L 40% of calories from fat Increased serum glucose, increased serum leptin, and
pancreatic β-cell hyperplasia and hypertrophy
Pancreas [61,75]
During the different period of G 40% of calories from fat Hyperglycemic, impaired insulin release, changesβ-cell
volume and number, reduced PDX-1 and GK expression
in β-cells
Pancreas [76,77]
2 weeks prior to mating, during G and L 18% fat (w/w) Reduced birth weight and weight gain on unsaturated
fatty acids diet, and fewer large islets on saturated fatty
acids diet
Pancreas [78]
(continued on next page)
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Table 1 (continued)
Animal Duration of maternal HFD Composition Effect (offspring) Organ affected
(offspring)
Ref
Rat 4 weeks prior to mating, during G 59% of calories from fat Increased serum insulin and altered expression of insulin
signaling proteins in skeletal muscle
Skeletal muscle [63]
10 weeks prior to mating 40% of calories from fat Increased abdominal adiposity, serum leptin and insulin – [108]
NHP Up to 4 years prior to mating 32% of calories from fat Altered fetal metabolite proﬁle, fetal thyroid axis,
expression and methylation of hypothalamic gene,
decreased fetal HDAC activity, SIRT1 gene expression and
activity, decreased fetal hepatic apoptosis, increased
placental inﬂammatory cytokines, placental dysfunction,
early lower body weight and decreased lean mass,
increased serum leptin, early onset obesity, increased
proinﬂammatory cytokine levels, modulated serotogenic
system, increased hepatic expression of the
gluconeogenic enzymes and transcription factor mRNA
Liver [81,82],
[84–89],
[93,94]
Up to 4 years prior to mating 36% of calories from fat Increased serum insulin Vasucular abnormality [83]
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fect differs depending on the quality of fat as well as the sex of the off-
spring. Furthermore, a PUFA or SFA diet throughout gestation and
lactation was associated with reduced docosahexaenoic acid (DHA) in
both liver and heart in comparison to control [43].
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of
liver disorders from steatosis to nonalcoholic steatohepatitis (NASH) as-
sociated with insulin resistance and the metabolic syndrome [44–46]. In
theoffspring,maternal HFD exposure has been associatedwith increased
triglyceride content, increased phosphoenolpyruvate carboxykinase 1
(PCK1) gene expression and increased c-jun N-terminal kinase (JNK)
and IκB kinase (IKK) phosphorylation which is consistent with develop-
ment of NAFLD. In addition, maternal HFD exposure has been shown to
reduce hepatic insulin signaling and basal acetyl-CoA carboxylase
(ACC) phosphorylation in the offspring [30]. Similar changes are ob-
served even when the offspring are weaned to a non-HFD. Interestingly,
exposure to HFD in utero has amore detrimental effect on the liver of the
offspring than does HFD after weaning [41]. Moderate steatosis and
NASH has been shown to be associated with increased expression of
genes of lipogenesis, oxidative stress and inﬂammation, in addition to al-
terations in activity of enzymes of the electron transport chain [37,47].
Further supporting that maternal HFD predisposes the offspring to
NAFLD, offspring exposed to a HFD developed hepatic steatosis; which
was more pronounced in the offspring exposed to HFD during gestation,
lactation and postweaning. HFD exposed offspring also had increased ex-
pression of sterol regulatory element binding protein-1c (SREBP-1c)
suggesting an effect on hepatic lipogenesis [37]. Offspring that are
weaned to the HFD appear to have a more pronounced effect suggesting
that there may be a “two hit” effect. A maternal HFD enhances offspring
susceptibility to liver dysfunction and NAFLD. Interestingly, in another
study therewasno effect ofmaternal diet onhepatic inﬂammation or ex-
pression of lipid metabolism genes [36]. It is plausible that the negative
outcomes reported in this study could be due to the young age of the
offspring.
In the fetus, amaternalHFDwas associatedwith increased hepatic ex-
pression of genes involved in glycolysis, gluconeogenesis, inﬂammation
andoxidative stress [40]. This provides insight into themechanism(s) un-
derlying insulin resistance and metabolic disease. The upregulation of
genes involved in glycolysis and gluconeogenesis suggest that the off-
spring is being programmed for hepatic insulin resistance. Additionally,
inﬂammation and oxidative stress has been implicated in the develop-
ment of metabolic disease.
Consistent with prior studies, female sex may have a protective
effect on the programming of the offspring liver. In female offspring,
exposure to a HFD in utero resulted in a reduction in hepatic triglyceride
content and increasedhepatic protein levels for cluster of differentiation
36 (CD36), carnitine palmitoyltransferase-1 (CPT-1) and peroxisomal
proliferator activated receptor α (PPARα) in an insulin-like
growth factor (IGF)2 dependent manner [48]. These changes can leadto upregulation of fatty acid oxidation in the liver, which is different
from that observed inmale offspring. HFD exposure in uterowas also as-
sociated with altered expression of miRNA in the HFD exposed female
offspring [48]. These data suggest liver is a major target for program-
ming during development [30,37,41,44–49].
Maternal HFD in utero has been shown to enhance offspring suscep-
tibility to type 2 diabetes [50]. One potential mechanism for this in-
volves alterations in pancreatic beta cell mass which could potentially
be transmitted to subsequent generations. Despite changes in diet,
type 2 diabetes was seen in F1 mice exposed to the HFD during fetal
or neonatal life and F2 mice whose mothers were exposed to the HFD
during fetal life. In the F1 generation, pancreatic beta cell mass, replica-
tion, and neogenesis were increased in animals exposed to HFD. In con-
trast, F2 mice had lower beta cell mass. In the F1 generation, the
exposure to HFD in utero had an even more dramatic effect when the
HFDwas also provided during the neonatal period [51]. These data sug-
gest exposure to a HFD during fetal life alters beta cell structure and
function thereby resulting in type 2 diabetes and this is transmissible
to their offspring (F2 generation) in the absence of an additional insult.
HF exposure in utero results in remodeling of the bone structure of
the offspring in a sexually dimorphicmanner. HFD has been shown to af-
fect bone structure and length [52]. Bone marrow adiposity was in-
creased and femur length decreased in male and female offspring.
Female offspring also demonstrated alterations in trabecular struc-
ture [52]. These data provide insight into the effect of a maternal HFD
on the skeletal structure of the offspring and how these alterations
may lead to the development of future disease such as osteoporosis.
Little is known about the effect of HFD exposure in utero on animal
behavior [53]. HFD exposed offspring displayed increased anxiety
(reduced time in open arms of elevated plus maze as well as increased
inhibition to consumenovel food) associatedwithmolecular changes in
the hippocampus (increased expression of bone-derived neurotrophic
factor (BDNF) and GABAA alpha2 receptor subunit (GABAA α2R)
and 5-hydroxytryptamine 1A (5HT1A) [53]. These data suggest a ma-
ternal HFD may increase anxiety behaviors in the offspring via alter-
ations in the GABAergic and neurotrophin systems in early life.
In conclusion, in HFD mouse models of DOHaD, it is clear that there
may be critical periods of vulnerability to the suboptimal environment.
In utero exposure seems to have a more dramatic effect offspring pro-
gramming. It is also clear that offspring have a sexually dimorphic re-
sponse to HFD exposure. In the mother, intake of a HFD resulted in
alterations in substrate utilization and/or changes in body composition.
Maternal HFD exposure does not have to be accompanied by maternal
obesity to impart metabolic changes to their offspring. In the offspring,
in utero exposure to HFD resulted in placenta dysfunction associated
with alterations in fetal growth, obesity, insulin resistance, hyperten-
sion, NAFLD, and altered pancreatic beta cell mass. These phenotypic
outcomes are associated with changes in organ structure as well as
gene expression in metabolically important organs (e.g., liver). Further
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to the rise in the metabolic disease incidence, these changes may be
passed on to subsequent generations without additional exposure to
the HFD.3. Rat
The interaction of pregnancy and dietary fat on the pregnancy out-
come as well as the metabolism in the offspring exposed to a maternal
HFD has also been investigated using rat models. In the ﬁeld of
DOHaD, Sprague–Dawley and Wistar rats are the two most frequently
used rat strains. When compared to mousemodels, rats present several
advantages including that they are bigger and easier to handle and they
could potentially bemore resistant to insults. The pregnancy duration is
longer and the fetuses are larger. In contrast to many commonly used
inbred strains of mice, Sprague–Dawley and Wistar rats are outbred
strains. Similar to mouse models, maternal HFD exposure in rats pro-
duces similar effects on the metabolic phenotype of the offspring as
well as organ speciﬁc effects including the liver and pancreas as well
as hypothalamic changes.
The Sprague–Dawley dams exposed to a HFD during pregnancy ex-
perienced increased body weight and elevated plasma insulin, glucose
and triglycerides levels [54], these effects are similar towhat is reported
in the mouse [29–31]. In addition, HF exposure has been shown to alter
the quality of breast milk. HFD breast milk had increased protein, cho-
lesterol, triglycerides [55] and leptin concentration [56,57]. These data
suggest alterations inmaternal milk compositionmay contribute to off-
spring obesity.
In the rat, amaternal HFDhas been shown to reduce fetal growth and
to alter the placental structure by reducing the placental junctional zone,
without altering the placental labyrinth zone [39]. These changes were
not accompanied by alterations in gene expression of perosixome
proliferator-activated receptor gamma (PPARγ) and vascular endothelial
growth factor A (VEGFa) which are markers of placental vascular
development. This study suggests mechanisms responsible for fetal
growth restriction may include effects on placental growth.
Similar to a HFD during pregnancy, maternal obesity secondary to
prolonged HF feeding was associated with an increase in offspring adi-
posity and increased serum leptin as well as reduced insulin tolerance
[57]. Consistent with mouse models, HFD in utero is sex dependent
and seems to bemore detrimental that exposure toHFDduring lactation.
Cross-fostering studies showed that in males in utero HFD exposure re-
sults in an increase in adiposity independent of the diet exposure during
lactation. In contrast, in females, signiﬁcant differences in adiposity were
associated with exposure to HFD in utero and during lactation [58,59].
The post-weaning diet also appears to affect offspring body composition.
When exposed to aHFD in utero andweaned to a “junk food”diet, female
offspring fromborderline hypertensive fathers are hyperphagic andhave
greater fat pad mass compared to controls [60]. They also had increased
fasting serum leptin and insulin levels. This suggests there is enhanced
susceptibility to metabolic disease when offspring exposed in utero to a
HFD are weaned to a junk food diet.
Similar to mouse models, HFD rat fetuses had enhanced susceptibil-
ity to the Metabolic Syndrome, HFD fetuses display hyperinsulinemia
and altered insulin secretory response to insulin secretagogues [54].
As adults, HFD offspring had increased adiposity, increased liver weight
and hepatic liver lipid content, increased blood glucose [61], triglycer-
ides [38] and plasma corticosterone levels, increased adipocyte area
and left ventricular wall thickness [62]. In addition, HFD offspring
were glucose intolerant, and their pancreatic islets, secreted more insu-
lin in response to low glucose stimuli. When weaned to a high sucrose
diet HF offspring displayed an impaired metabolic proﬁle (increased
body weight, impaired glucose tolerance and increased FFA) compared
to thoseweaned to LFD [54]. These data further support the negative ef-
fects of a maternal HFD and its contribution to metabolic disease in theoffspring. Furthermore, if the offspring are also weaned to an adverse
diet, this worsens their metabolic proﬁle.
Similar to mouse models the diet composition plays a major role in
the offspring phenotype. A diet rich in omega-6 polyunsaturated fat
programs offspring for Metabolic Syndome. Speciﬁcally, early life expo-
sure to a diet rich on omega-6 PUFA diet has been shown to increase
total and abdominal adiposity. Hyperinsulinemia and altered hepatic
triglyceride content, in associationwith changes in expression of several
insulin signaling genes in the skeletal muscle, suggest insulin resistance
is also present [63]. These data demonstrate that adverse maternal nu-
trition results in multiple negative outcomes that program offspring
for metabolic disease in later life.
This susceptibility to the Metabolic Syndrome, is further enhanced
by alterations in the hepatic mitochondria content in response to the
HFD exposure. Wistar rats exposed to HFD during pregnancy had a de-
creased copy number of mitochondrial DNA in liver regardless of off-
spring sex or weaning diet. There was a male speciﬁc reduction of
hepatic PGC1αmRNAwhich had a signiﬁcant effect on peripheral insu-
lin resistance (higher HOMA-IR) with the opposite effect being ob-
served in the female offspring [59]. Furthermore, exposure to a HFD in
utero resulted in a reduction in DHA in liver lipids in the offspring
[64]. This suggests a maternal HFD results in alterations in the fatty
acid proﬁle of the liver and a decrease in the levels of an essential lipid.
As observed in mice, several rat models have also demonstrated al-
tered cardiovascular function following exposure to a maternal HFD.
Studies have reported increases in diastolic, systolic and mean arterial
blood pressure in older female offspring exposed to a maternal HFD
[65]. In contrast, another study using female offspring from borderline
hypertensive fathers exposed to a HFD in utero and weaned to either
control or a “junk food” diet reported lower mean arterial and diastolic
blood pressure in HFD exposed offspring in comparison to controls.
Whereas there was no difference in blood pressure in offspring placed
on different postweaning diets [60]. While the results from both studies
are not consistent, the effect of the borderline hypertensive father used
in one mating strategy cannot be ignored. Furthermore, these studies
clearly demonstrate that a HFD in utero results in cardiovascular dys-
function. Additionally, cross-fostering studies showed that in utero
HFD exposed male offspring suckled by a control dam compared with
HFD offspring suckled by the same damhad no difference in blood pres-
sure. However, female offspring of fat fed dams suckled by a control
dam and control offspring suckled by a fat fed dam were hypertensive
[58]. There appears to be a sex-dependent susceptibility to these cardio-
vascular outcomes, with the female offspring being more susceptible.
All offspring exposed to the HFD during gestation or during suckling
demonstrated endothelial dysfunction seen as a blunting of acetylcho-
line (Ach) induced relaxation in mesenteric arteries [58]. HFD exposure
was associated with a reduction in themaximal endothelial-dependent
relaxation to Ach in small mesenteric arteries in comparison to control
animals [65]. Furthermore, there was a reduction in aortic endothelial
cell layer volume and smooth muscle number, increased aortic stiffness
and reduced endothelium-dependent relaxation in comparison to
control. In the kidney, glomerular number and volume was altered
depending on the maternal diet. Additionally, renin and Na+, K+-
ATPase activity was reduced in offspring exposed to a maternal HFD
[66]. This suggests that a maternal HFD programs hypertension via al-
terations in the vascular and renal structure of the offspring. Follow up
studies in the HFD adult female offspring demonstrated a decrease in
mtDNA content in kidney and alterations in the expression of genes
such as AJ223355 (mitochondrial dicarboxylate carrier) and D12770
(mitochondrial adenine nucleotide transporter) in aorta that suggested
mitochondrial dysfunction [67].
Consistent with vascular dysfunction the femoral arteries of off-
spring of HFD diabetic mothers fed a HFD during pregnancy, had an en-
hanced sensitivity to norephinephrine with a decreased or blunted
arterial relaxation in response to Ach [68,69]. These alterations, which
enhance offspring susceptibility to cardiovascular dysfunction, were
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cluding decreased arachidonic acid and DHA content, which are
cardioprotective fatty acids [69]. Diabetes was induced via streptozocin
on day 1 or 2 of pregnancy. In this case there are two possible mecha-
nisms for the programming effects seen in the offspring; the maternal
HFD and the maternal diabetes.
The predictive adaptive response (PAR) was investigated in a
Sprague–Dawley rat model [70]. The outcomes demonstrate that the
PAR to a maternal HFD prevents endothelial dysfunction but not hyper-
tension in the adult offspring of Sprague–Dawley rats. There was a
partial protection from the cardiovascular effects ofmaternal HFD expo-
sure displayed by the offspring when re-exposed to a HFD in later life
displayed. However, the female offspring were hypertensive when
maintained on the same HFD diet as their mothers [70]. This study sug-
gests the adverse effects of maternal HFD diet on blood pressuremay be
irreversible.
The impact of maternal HFD on hypothalamic leptin sensitivity has
been investigated inHFD ratmodels.Male and female offspring exposed
to a HFD in utero and weaned to a HFD had altered feed efﬁciency [71].
In addition, in offspring exposed toHFD in utero, STAT3phosphorylation
in response to leptin was abolished suggesting hypothalamic leptin re-
sistance [71]. Similarly, decreased STAT3 and IRS-2 protein expression
was detected in the hypothalamus of HFD exposed offspring [72].
These changes were accompanied by an increase in mRNA levels of in-
sulin receptor β (IRβ) and leptin long receptor (OB-Rb). Alterations in
gene expression were also detected in the hypothalamus. Speciﬁcally,
increasedmRNA levels of neuropeptide Y (NPY), Agouti-related peptide
(AGRP) pro-opiatemelanocortin (POMC), and melanocortin receptor-4
(MC4R) were reported. This outcome is consistent with hypothalamic
dysregulation after exposure to a HFD in utero being associated with
upregulation of the orexigenic (appetite stimulating) neuropeptides
during early development. In addition, HFD in utero stimulated the pro-
liferation of neuroepithelial and neuronal precursor cells of the embry-
onic hypothalamic third ventricle, as well as stimulated proliferation
anddifferentiation of neurons and theirmigration toward hypothalamic
areas [73]. HFD increased expression of orexigenic peptides, galanin,
enkephalin and dynorphin in the paraventricular nucleus (PVN) and
orexin and melanin-concentrating hormone in the perifornical lateral
hypothalamus (PFLH) of the offspring [73]. In addition to changes
in the appetite centers, females developed precocious puberty (days
29–32 in comparison to days 33–36 in balanced diet offspring). This
data suggests the mechanisms involved in hyperphagia and increased
adiposity seen in offspring exposed to HFD in utero may include in-
creased neurogenesis as well as stimulation of hypothalamic peptides.
Several studies have investigated the effects of a HFD at different pe-
riods within gestation and lactation. A HFD exposure during critical pe-
riods of development alters pancreatic morphology and function.
Changes in glucokinase (GK) and pancreatic and duodenal homeobox
1 (PDX-1) immunoreactivity expression has been observed in offspring
exposed to a HFD in utero. When HFD diet exposure was limited to the
gestation period PDX-1 and GKmRNA expression and immunoreactivi-
ty were unaffected and the impairment in glucose tolerance was less
pronounced [74]. HFD exposure during development was also associat-
ed with pancreatic alpha and beta cell hyperplasia, increased pancreatic
acinar cell proliferation and changes in beta and alpha cell size [75,76] as
well as impaired glucose stimulated insulin release [77]. This suggests
an adverse programming effect on beta cell function may predispose
offspring to beta cell failure.
The effect of fatty acid composition of the maternal diet on fetal and
postnatal growth, and pancreas morphology was examined [78]. A HFD
rich in unsaturated fat (UFA:menhaden ﬁsh oil) was associated with an
increase in pancreatic islet numbers. A diet rich in saturated fat (SFA: co-
conut oil) was associated with a reduction in the number of large islets
and a faster andmore robust insulin response to a glucose load [78]. The
programming effect on the pancreas alters the structure and function of
islets associated with a predisposition towards glucose intolerance anddiabetes. These data demonstrate the fatty acid composition of
the maternal diet is important as the diets rich in saturated fatty acids
and unsaturated fatty acids had opposite effects on pancreatic islet de-
velopment and insulin response of offspring.
In conclusion, despite the size and breed differences between the
mouse and rats, in rodent models, no major differences have been ob-
served in the phenotype of their respective offspring exposed to a ma-
ternal HFD. In both models, the effects were seen in a sex-dependent
manner during critical stages of development. Similar to the mouse
model, a maternal HFD in rats affects offspring body composition, glu-
cose and lipid metabolism, endothelial and vascular function and
blood pressure, liver function, pancreatic morphology, pancreatic func-
tion and hypothalamic signaling. Hypothalamic reprogramming of off-
spring exposed to a maternal HFD results in altered expression of
hypothalamic peptides that regulate food intake and weight gain that,
in the long term, may affect offspring behavior and physiology.
Summarized in Fig. 1 are the effects of a maternal HFD on various
organ systemsof exposed offspringderived from several animalmodels.
These effects vary based on the animal model, timing and duration of
the HFD exposure, as well as the gender of the offspring. The program-
ming effects are further enhanced if the exposure is extended to the
post-weaning period. Although not implicated in these studies, future
work in the ﬁeld could point to the gut microbiota as a potential source
of programming [79,80].
4. Non-human primates
The effect of a maternal HFD on the offspring has also been investi-
gated in non-human primates (NHP). Similar to the rodent models,
NHPs exposed to a maternal HFD is associated with predisposition to
metabolic disease associated with effects inmultiple organ systems (in-
cluding liver and placenta), as well as circulating factors in the mother
and her offspring. Additionally, several of these studies have focused
on epigenetic factors that may explain the increased susceptibility to
metabolic disease in response to early life exposure to HFD. Many of
these changes are observed during fetal life (prior to birth), which sug-
gests that the intrauterine environment is a period vulnerable to nutri-
ent perturbations.
At 5–7 years of age, female Japanesemacaqueswere fed a C or a HFD
for 2–4 years. A subset of these NHPs were switched from HFD to nor-
mal chow 1–3 months before becoming pregnant in the ﬁfth year of
the study [81]. Animals fed the HFD were divided into two groups
based on their weight gain and insulin resistance and were considered
either sensitive to theHFD (HFD-S) or resistant to theHFD (HFD-R). Ap-
proximately 60% of the NHPs were categorized as HFD-S. The fetal
(e130) offspring of HFD (O-HFD) NHPs had lower body weight com-
pared to CD offspring, which was likely due to decreased lean body
mass. These data suggest, regardless of the mother's insulin status, a
HFD in utero results in the offspring being born smaller than control.
The consumption of a HFD during pregnancy was shown to alter
fetal placental hemodynamics [82]. Uterine hemodynamic parameters
were examined in early third-trimester pregnancies (gestational day
120). Uterine artery blood ﬂow volume was decreased in both HFD-R
(38% reduction) and HFD-S (56% reduction). A maternal HFD resulted
in expression of increased placental inﬂammatory cytokines (IL-1β
and Monocyte Chemotactic Protein-1 (MCP-1) and increased expres-
sion of toll-like receptor 4 (TLR4R) associated with an increase in the
frequency of placental infarctions and stillbirth. These data suggest
that maternal obesity and insulin resistance associated with chronic
consumption of a HFD exacerbates placental dysfunction and results
in an increased frequency of stillbirth seen in HFD pregnancies in gener-
al [82]. In agreement to what is seen in rodents, a maternal HFD results
in placental alterations. In the rodent, studies reported alterations in
placenta structure and nutrient transport, whereas placental inﬂamma-
tionwas investigated in NHPs. The potential role of placenta in offspring
programming is very important as maternal factors can cross the
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Fig. 1. Organ-speciﬁc pathologies associated with exposure to a maternal HF diet.
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growth and development. In the NHP inﬂammation of the placenta
resulted in adverse effects including increased stillbirth.
The impact of a maternal HFD on cardiovascular disease was exam-
ined in 13 month old offspring by investigating endothelial function
[83]. The mothers were fed the same diet discussed in previous studies
and after weaning the offspring were either maintained on the same
diet (CD/CD, HFD/HFD), or switched to the opposite diet (CD/HFD,
HFD/CD). HFD/HFD juveniles showed increased plasma insulin level
and glucose-stimulated insulin secretion compared to CD/CD. In ab-
dominal aorta, HFD/HFD juveniles showed decreased Ach-induced va-
sorelaxation compared to CD/CD. HFD/HFD animals also showed a
thicker intima wall and an abnormal vascular morphology. mRNA ex-
pression of proinﬂammatory factors such as vascular endothelial
growth factor A (VEGFA), TNFα and Intercellular adhesion molecule 1
(ICAM-1) were increased in HFD/HFD compared to CD/CD in the ab-
dominal aorta tissue. Post-weaning diet reversal (HFD/CD) did not re-
verse the expression of VEGFA or TNFα, however, ICAM-1 tended to
be lower in the HFD/CD animals compared to HFD/HFD. These data sug-
gest a maternal HFD exposure, as well as a post-weaning HFD exposure,
affects endothelial function and this is partially reversed by switching to
the CD [83].
Using NHP it has been demonstrated that a maternal HFD is associat-
edwith decreased plasma n−3 fatty acids (FA) and fetal hepatic apopto-
sis [84]. Lipid analysis of fetal andmaternal plasma revealed total n−3 FA
and DHA levels were signiﬁcantly lower in the HFD compared to the CD
group. Also, the n−6:n−3 ratio was increased and correlated with thematernal ratio in the HFD group. Furthermore, the number of apoptotic
cells was increased in the HFD fetal liver compared to CD and switching
the diet normalized the fetal DHA, n−3 FAs and hepatic apoptosis to
CD levels. The HFD also had an effect on the breast milk composition
such that mothers consuming a HFD displayed lower levels of
eicosopentanoic acid and DHA [84]. Alterations in the composition of
milk have also been reported in the rodent. These compositional changes
canbe apotentialmechanismunderlying offspringphenotypic outcomes.
Fetal O-HFD had increased triglycerides and increased evidence of
hepatic oxidative stress that are early signs of NAFLD, similar to what
is reported for rodent models. Increased triglyceride levels and fatty
liver is a feature of maternal HFD programming that occurs in rodent
and NHP models. Furthermore, when the offspring are also weaned to
a HFD they have a more adverse effect [81]. Exposure to a maternal
HFD resulted in increased liver triglycerides and histologic evidence
of NAFLD. These hepatic changes were associated with signiﬁcant
hyperacetylation at H3K14 and a trend towards increased H3K9 and
H3K18 acetylation in fetal HFD liver [85]. Fetal HDAC1 mRNA and
protein expression were signiﬁcantly decreased, as was in vitro HDAC
activity. Fetal hepatic AcH3K14 ‘reprogrammed’ genes (Glutamic pyru-
vate transaminase 2 (GPT2), DnaJ homolog subfamily A member 2
(DNAJA2) and Retinol dehydrogenase 12 (RDH12)) were increased by
exposure to a maternal HFD [85]. These data suggest epigenetic modiﬁ-
cations involving alterations to chromatin structure may be the molec-
ular basis of the outcomes seen in offspring exposed to a maternal HFD.
Glycerol levels were higher in O-HFD NHPs compared to CD fetal
offspring. Fetal O-HFD exhibited elevated hepatic expression of the
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(G6P), fructose-1,6-bisphosphatase 1 (FBP1), PCK1, PGC1α, and hepato-
cyte nuclear factor 4α (HNF4α) protein was signiﬁcantly elevated
compared to CD liver. Maternal diet reversal improved fetal hepatic tri-
glyceride levels and partially normalized the mRNA expression of the
gluconeogenic genes. Furthermore, the offspring hadnormal total triglyc-
eride and glycerol levels [81]. Metabolomic analysis of the fetal serum
revealed signiﬁcant alterations in theHFDexposed offspring [86]. Twenty
two metabolites had statistical signiﬁcance over the entire study
and eight metabolites (2-hydroxybutyrate, ascorbic acid, α-tocopherol,
cholesterol, 3-hydroxybutyrate, un(1462_100), un(1574_304) and
un(1952_334) were differentially present in serum of HFD-exposed
compared CD offspring [86]. These data suggest alterations in the fetal
metabolite proﬁle occur in response to a maternal HFD and may play a
role in the development of metabolic disease.
Since sirtuin 1 (SIRT1) is a lysine deacetylase and has been shown to
play a role in cellularmetabolism, itwas hypothesized that SIRT1may be
involved in the altered H3K14ac seen in liver of HFD offspring. Fetal he-
patic SIRT1 gene expression, protein level, and activity were all found to
be dysregulated following exposure to a maternal HFD [87]. In addition,
the SIRT1-associated genes, peroxisome proliferator-activated receptor
gamma (PPARγ), PPARα, sterol regulatory element-binding transcrip-
tion factor 1 (SREBF1), cholesterol 7 alpha-hydroxylase (CYP7A1),
fatty acid synthase (FAS) and stearoyl-CoA desaturase (SCD) were in-
creased in the fetal macaque liver with HFD exposure. These ﬁndings
suggest that SIRT1 likely plays a key role in remodeling the fetal hepatic
epigenome and metabolome in a HFD milieu [87]. These are all key
genes involved in fat and cholesterol metabolism and may correlate
fetal lipid oxidation and NAFLD [87].
Using the same experimental paradigm the effects of fetal exposure
toHFD on the development of themelanocortin system in the hypothal-
amus was investigated [88]. Third-trimester fetuses from mothers on
HFD showed increased POMC and decreased AGRP mRNA expression
in the hypothalamus. A cytokine array showed eight inﬂammatory fac-
tors and receptors, namely IL-1β, Interleukin-1 receptor type I (IL-1R1),
Interleukin-1 familymember 6 (IL-1F6), Interleukin-1 familymember 7
(IL-1F7), Chemokine (C-C motif) ligand 26 (CCL26), Chemokine (C-C
motif) receptor 3 (CCR3), Chemokine (C-C motif) ligand 19 (CCL19)
and Chemokine (C-C motif) ligand 2 (CCL2) were increased in the
hypothalamus of fetus exposed to a maternal HFD. Reversing the diet
normalized fetal POMC and AGRP mRNA expression as well as circulat-
ing cortisol and cytokine levels. These results suggest chronic consump-
tion of a HFD during pregnancy leads to widespread activation of
proinﬂammatory cytokines that affect development of themelanocortin
system in a way that can be reversed by a healthy maternal diet [88].
The effect of exposure to a maternal HFD on the peripheral circadian
system has also been examined in this NHP model [89]. Exposure to a
maternal HFD resulted in alteration in fetal hepatic neuronal PAS do-
main protein 2 (NPAS2), a paralog of the clock transcription factor,
gene expression and switching to a LFmaternal diet normalized this ef-
fect. Expression of other circadian genes was also affected by exposure
to a maternal HFD. In particular, period circadian protein homolog 1
(PER1) and nuclear receptor subfamily 1, group D, member 1(Rev-
erb-α) mRNAs were up-regulated in fetal liver of HFD compared to CD
NHPs. The NPAS2 promoter did not display alterations in DNAmethyla-
tion at any CpG dinucleotide between CD and HFD exposed animals
suggesting another epigenetic modiﬁcation may be responsible for al-
teration in NPAS2 gene expression. To address the hypothesis that the
change in NPAS2 gene expression may be due to alterations in histone
modiﬁcations in the functional promoter, an antibody against H3K14
was used. There was signiﬁcant enrichment for the Rev-erb-α/ROR re-
sponse element promoter region, which drives NPAS2 transcription, in
NHPs exposed in utero to amaternal HFD compared to CD aswell as sig-
niﬁcant increase in enrichment of promoter occupancy with the gene
activatingmark, H3K14ac [89]. These changes in expression of circadian
genes, and the observed epigenetic modiﬁcations, may be important inprogrammingmetabolic disease since disruption of circadian rhythmic-
ity is associated with obesity and cardiovascular disease [90–92].
Thyroid hormonehomeostasiswas investigated in thematernal HFD
NHP model because of its effects on development and energy balance
[93]. Fetal free T3 was not changed but free T4 was signiﬁcantly de-
creased in the maternal HFD exposed offspring compared to CD off-
spring. Since thyroid hormones are important regulators of fetal
development and energy balance, alterations in the thyroid hormone
homeostasis could be an underlying mechanism for the development
of metabolic disease in later life. Analysis of expression of genes in-
volved in thyroid function (thyrotropin releasing hormone (TRH), thy-
roid stimulating hormone receptor (TSHR), thyroglobulin (TRHR),
thyroid peroxidase (TPO), and sodium iodide symporter/solute carrier
family 5 member 5 (SLC5A5)) showed a decrease in the hypothalamus
and thyroid gland. Additionally, transcription of the deiodinase
iodothyroine (DIO) gene that helps to maintain thyroid homeostasis
was dysregulated in the fetal liver, thyroid and hypothalamus. Chroma-
tin immunoprecipitation (ChIP) showed that the thyroid response ele-
ment (TRE) of the thyroid hormone receptor beta (THRB) is associated
with an increase in deacetylation of histone H3 at lysines 9 and 14
(H3K9,14 ac) in liver of NHPs exposed to amaternal HFD. This data sug-
gests a maternal HFDmodiﬁes the histone code and thus alters the fetal
thyroid axis and thyroid gene expression [93].
The serotonergic system, which is involved in behavioral disorders,
was also investigated in NHP fetuses on gestational day 130 (G130;
early 3rd trimester; full term is 175 days) from CD and HFD mothers
[94]. Maternal HFD consumption was associated with perturbations in
the serotonergic systemof fetal offspring. Female, but notmale, HFD off-
spring exhibited increased latency to touch a potentially threatening
novel object as compared to CD offspringwhile none of the CD offspring
ormale HFD offspring exhibited increased latency. HFD female offspring
also took longer than CD female offspring to touch a threatening object,
whilemale CD andHFD offspringwere not different. These results show
that amaternal HFD increases anxiety-like behavior in a sexually dimor-
phic manner [94]. Similarly, in mice [53], increased anxiety and alter-
ations in brain circuitry suggest a maternal HFD increases the risk of
developing behavioral disorders.
In conclusion, these studies demonstrate that NHPoffspring exposed
to a maternal HFD have altered glucose metabolism, liver and thyroid
functions, circadian rhythm, hepatic gene expression and histone mod-
iﬁcations. Thus, the same thephenotypic changes observed in rodents in
response to a maternal HFD are manifested in this NPH model that is
much closer to humans. Interestingly, in the NHP models many of the
negative effects induced by the maternal HFD were reversible when
the diet was switched postnatally or prior to pregnancy. Studies using
rodent models demonstrate that exposure to a HFD in utero has a
more profound effect than exposure during lactation only. While
switching the diets did not completely reverse the effects, improved
metabolic outcomes were observed in the offspring.
5. Epigenetic effects
Epigenetics is the study of heritable changes in gene expression
without changes in the underlying DNA sequence. Epigenetic effects
have also been examined in rodentmodels exposed ofmaternal HFD ex-
posure. As described above in theNHP,many of the phenotypic changes
observed in the HFD exposed offspring could be linked to alterations of
the epigenome [85,87,89,93]. Histone modiﬁcations at the adiponectin
(ADIPOQ) and leptin (LEP) genes were examined in mice exposed to a
maternal HFD [95]. Female 8 week old ICR mice consumed either a CD
(12% fat) or HFD (62% fat) for 4 weeks and males were fed CD for
4 weeks before mating. All offspring were weaned to CD at postnatal
day 21. OH mice (offspring from mothers exposed to an HFD during
pregnancy) were heavier than OC (offspring from mothers exposed to
an CD during pregnancy) mice. Systolic blood pressure in OH mice
was elevated, and they had impaired glucose tolerance compared to
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Fig. 2.Overview of events that occur in response to exposure to amaternal HF diet and in-
creased susceptibility to metabolic disease.
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ide lower compared to OC. This was in association with increased LEP
and ADIPOQmRNA expression inwhite adipose tissue of OH. The acetyl
H3K9 level in the ADIPOQ promoter region was lower and the dimethyl
H3K9was increased in adipose tissue in OHmice compared to OCmice.
On the other hand, the monomethyl H4K20 level was signiﬁcantly in-
creased in the LEP promoter region of OH compared to OC mice [95].
This study demonstrates that maternal HFD induced metabolic syn-
drome leads to epigenetic modiﬁcations of adiponectin and leptin and
their gene expression.
Vucetic et al. have demonstrated that there are alterations in the
gene expression and methylation of the hypothalamic dopamine
genes using the C57BL/6J mouse model of maternal HFD [96]. Females
were maintained on either CD (12% fat) or HFD (60% fat) for 3 months
before breeding with DBA/2J males. HFD was maintained through
lactation and offspring were weaned to the CD. Expression of the
preproenkephalin (PENK) and opioid receptor mu 1 (MOR) genes
were increased in the nucleus accumbens, prefrontal cortex and hypo-
thalamus. This was correlated with hypomethylation of the promoter
region of these genes in the nucleus accumbens (NAc) and hypothala-
mus. Similarly, dopamine reuptake transporter (SLC6A3)mRNAwas in-
creased in the NAc and this was also associated with hypomethylation
of the SLC6A3 promoter region [96]. These results show that alterations
in CpG methylation of DNA is associated with altered expression genes
in brain regions and with energy balance andmotivated feeding behav-
ior present in offspring exposed to a maternal HFD and they demon-
strated a preference for palatable foods. This is a plausible mechanism
for epigenetic transfer of the phenotype as the maternal HFD was able
to change themethylationmarks of the offspring. Additionally, these re-
sults are largely consistent with what is known about effects of CpG
methylation of DNA in a promoter on gene expression [97].
Fetal gluconeogenic gene expression and potential regulatorymech-
anisms related to histonemodiﬁcationswere examined in anobesity re-
sistant strain of rats (Crl:OR(CD)) [98]. Females consumed a CD (16%
fat) or a HFD (45% fat) throughout gestation. Hepatic mRNA expression
of PCK1 was higher in HFD compared to CD offspring. ChIP analysis
of the hepatic PCK1 promoter showed the decreasing of H3Ac,
H3K4Me2, H3K9Me3 and H3K27Me3 [98], though the analysis of
PCK1 coding region and upstream showed the increasing of H4Ac and
H3K4Me2. These results suggest that maternal HFD leads to certain his-
tonemodiﬁcations that are associated with transcriptional activation of
amain control point for the regulation of gluconeogenesis that could re-
sult in elevated glucose production and reduced insulin sensitivity.
To address the question if the variation in the type and amount of
maternal HFD leads to epigenetic regulation of hepatic fatty acid
desaturase 2 (FADS2) gene expression, female Wistar rats were fed ei-
ther 3.5% (LFD), 7% [adequate fat (AFD)] or 21% (HFD) butter or ﬁsh
oil (FO) from 14 days beforemating and throughout pregnancy and lac-
tation [99]. Offspring were weaned to a diet containing 4% fat (soybean
oil). Increasing the amount of fat in the maternal diet decreased FADS2
mRNA expression in liver of offspring. The methylation status of the
proximal promoter of FADS2 was increased with the amount of fat in
the maternal diet, while the level of methylation tended to be greater
in offspring of mothers fed FO compared to those fed butter fat. Methyl-
ation of CpG −394 showed a strong negative correlation with FADS2
mRNA expression in offspring, while CpGs−623,−84 and−76 corre-
lated weakly with FADS2 mRNA expression. Methylation of CpG−394,
but not CpGs−623,−84 and−76 correlated negatively with the pro-
portions of 20:4n−6 and 22:6n−3 in liver PC and PE of the offspring
[99]. Further studies have revealed that there were signiﬁcant single
factor effects of the amount of maternal dietary fat on the methylation
of CpG−394 of the FADS2 gene [100]. These data demonstrate that al-
terations in the amount and type of maternal dietary fat may result in
epigenetic modiﬁcations in the offspring.
All of these studies show that exposure to a maternal HFD is corre-
lated with epigenetic changes in the offspring as well as alterations ingene expression and dysregulation of various key metabolic pathways.
The mechanism(s) by which metabolic disease develops is quite com-
plex and involvesmultiple factors, however alteration of the epigenome
appears to play a signiﬁcant role in this process.
Fig. 2 summarizes the pathways bywhich exposure to amaternal HF
diet may alter offspring development and manifestation of metabolic
disease. Speciﬁcally, exposure to amaternal HF diet may reprogram off-
spring development through epigenetic modiﬁcations that impart a
molecularmemory of an adverse early lifemilieu.Maternal HFdiet is as-
sociatedwith altered fetal growth and a precocious increase in adiposity
and insulin resistance. Also, pathologic effects upon serum metabolites
and cytokines are observed in exposed offspring as well as alterations
in gene expression and tissue morphology in major organs. In sum,
these changes dramatically increase offspring risk for development of
metabolic disease. This highlights the importance of the maternal envi-
ronment and its impact on the lifelong health of the offspring.6. Paternal effect
While this article focuses on the programming effects of a maternal
HFD, the contribution of the father cannot be ignored [101]. In an article
byNg et al., it was shownusing Sprague–Dawley rats that chronic pater-
nal consumption of a HFD had profound effects on the pancreatic beta-
cell function of female offspring. In this study, male Sprague–Dawley
founder rats fed either CD or HFD (43% fat) were mated with females
consuming a CD. The female offspring from HFD fed fathers had in-
creased blood glucose and reduced insulin secretion. A paternal HFD re-
duced relative islet area and beta-cell area in female offspring that is
typically associated with impaired beta-cell replication. Pancreatic
gene expression revealed differentially expressed genes involved in
calcium signaling pathway mitogen activated protein kinase (MAPK)
pathway and wingless type MMTV integration site (Wnt) signaling
pathways, apoptosis, and the cell cycle [102]. Dunn andBale also report-
ed that the effect of a HFD was passed through the paternal lineage in
C57Bl/6:129 hybrid mice [31,103]. Several other studies also reported
that HFD induced paternal obesity is associated with impaired embryo
development and diminished reproductive health of their offspring
[104–107]. This impaired development coincided with embryonic ge-
nome activation suggesting paternal obesity affects sperm, possibly at
the genetic or epigenetic level. These data demonstrate that paternal
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be more susceptible to this perturbation.
In C57Bl/6:129 hybrid mice, a maternal HFD (45% fat) resulted in in-
creased body length and decreased insulin sensitivity in the offspring for
two generations and that these outcomes were transmitted via the ma-
ternal or the paternal lineage. Mothers were fed HFD for 4 weeks prior
to mating and throughout gestation and lactation and control mice
were fed a chow diet (12% fat) [31]. Both E17 embryos and male and fe-
male HFD exposed adult offspring had increased body length in compar-
ison to control offspring. In the F2 generation the effect of in utero HFD
exposure to fathers was investigated and the effects on the offspring
were enhanced if both maternal and paternal lines were exposed to
HFD in utero versus only one or the other. Offspring exposed tomaternal
or paternal HFD showed decreased insulin sensitivity in the F1 and F2
generations. F1 and F2 females exposed to HFD in utero had increased
plasma levels of IGF-I and increased hypothalamic expression of Growth
hormone secretagogue receptor (GHSR).Methylation studies of GHSRon
micropunches of the arcuate nucleus showed decreased methylation at
the GHSR promoter in both maternal and paternal lineages [31]. This
study was extended to the F3 generation since the primordial germ
cells of the ﬁrst generation mice may have been affected by the gesta-
tional exposure to HFD. The effect of HFD on weight and length only oc-
curred in females and was only passed through the paternal lineage
[103]. Imprinted genes showed a trend in paternally expressed genes
to have a “greater volatility of expression” (genes that show greater
than 50% deviation from baseline) in comparison to maternally
expressed genes [103]. These data clearly demonstrate both maternal
and paternal HFD can inﬂuence offspring susceptibility to metabolic dis-
ease. The mechanisms underlying this susceptibility may be explained
via epigenetic modiﬁcations perhaps at the level of imprinted genes.
In a study using Sprague–Dawley rats exposed to a HFD (from both
mother and father) increased body fat accumulation was observed in
male offspring. Male and female rats were fed a HFD (40% fat) or LFD
(5% fat) andmated to the same diet group [108]. The offspringwere nur-
tured by their ownmothers andweaned to aHFD or LFD (experiment 1),
by an F344 chow fed foster mother (experiment 2), or 2 days after mat-
ing, the fertilized eggs were collected from HFD or LFD mothers and
transplanted to the oviducts of a sham pregnant foster mother fed a
12% fat diet (experiment 3) and subsequently weaned to a HFD only
for 12–17 weeks (experiments 2,3). The total body weight and abdomi-
nal tissue weight was signiﬁcantly greater in male offspring of HFD par-
ents regardless of weaning diet and plasma leptin concentrations were
increased in comparison to control. Both HFD–LFD and HFD–HFD off-
spring had increased food intake and food efﬁciency however, weaning
to the HFD enhanced this effect [108]. Although the maternal and pater-
nal contributions were not separated in this study the various parental
contributions to programmedmetabolic disturbances in offspring should
not be ignored.
These studies demonstrate that, as with the mother, paternal envi-
ronmental exposures can also inﬂuence the health of their offspring;
thoughmaternal and paternal programming effects vary in their potency.
7. Sexual dimorphism
The studies discussed above predominantly focus on the male off-
spring. However, studies that investigate the effects of a maternal HFD
on both sexes demonstrate sex-speciﬁc responses to nutrient perturba-
tion during development [33,49,51,52]. Female hormones may play a
protective role in the development of insulin resistance and associated
disorders and may be the basis of some of the results seen. However,
other studies have shown that the females aremore susceptible, especial-
ly when the insult is from the paternal lineage [102,103]. Not only are
these changes seen after birth, several studies reported sex speciﬁc differ-
ences in the placenta during fetal life. Mao et al. examined the impact of
diet and fetal sex on placental gene expression in NIH Swiss female mice
fed CD, LFD or HFD [109]. At day 12.5 of pregnancy, the placenta geneexpression patterns of male offspring clearly clustered separately from
the placenta of females and the female placenta showed more striking
changes in gene expression in response to maternal diet than male pla-
centa [110]. Gallou-Kabani et al. also reported the effect of HFD on sexual
dimorphism in the placenta. Twenty imprinted genes were examined
and sexual dimorphism and sensitivity to diet were observed for nine
of these genes. Additionally, exposure to aHFDduring gestation triggered
sex-speciﬁc epigenetic alterations within CpG and throughout the ge-
nome [111]. Another study inmice also identiﬁed differential expression
at imprinted genes and suggested that these may be at least partially re-
sponsible for the sex-speciﬁc differences between offspring [103].
These studies suggest the mechanism for developing metabolic
disease may be sex-dependent, with one sex being more sensitive/
susceptible than the other to a particular perturbation. Themechanism
for this susceptibility may involve sex-dependent epigenetic modiﬁca-
tions. This emphasizes the importance of studying the response of
both sexes to dietary interventions.
8. Transgenerational effect
As discussed above, maternal HFD leads to obesity and metabolic
syndrome in the ﬁrst-generation (F1) offspring. Furthermore, recent
studies show that the F1 can transmit a similar phenotype to the second
(F2) or third generation (F3). Using C57BL/6:129hybridmice, Dunn and
Bale reported that maternal HFD exposure results in the increasing of
body length in the F2 generation and also found that the heritable
feature of reduced insulin sensitivity could be seen for at least two gen-
erations [31]. Moreover, they found the increase in body sizewas trans-
mitted to F3 females [103]. The imprinted gene array detected a
potential dynamic pattern of paternally expressed genes from thepater-
nal lineage that was not noted in the maternal lineage.
These studies demonstrate that either the maternal or the paternal
environment can affect programming events at imprinted loci associat-
ed with developmental regulation of growth and body size in future
generations.
9. Concluding remarks
It is well known that the maternal nutritional environment plays an
important role in determining offspring susceptibility to metabolic dis-
eases. The studies reviewed here demonstrate that maternal HFD expo-
sure during pregnancy and/or lactation increases offspring risk for the
development of metabolic diseases such as type 2 diabetes and obesity.
Direct evidence linking speciﬁc HFD exposure and metabolic disease in
humans is limited, however animal models, such as those described
here, provide signiﬁcant insight into the molecular changes associated
with this condition, while implicating an epigenetic basis for these dis-
eases. Interestingly, independent of the animal model studied, all
models showed similar phenotypic aswell as structural changes inmet-
abolically relevant organs as well as molecular changes when exposed
to a HFD in utero. The changes were sex speciﬁc, happened during a
critical period of development, were transmitted by the mother as
well as the father, andwere seen in subsequent generations. In addition,
these symptoms were accompanied by changes in expression of key
genes involved in metabolic and inﬂammatory pathways and were
sometimes associated with changes in DNA methylation or histone
post-translational modiﬁcations. Thus, even though the mechanism by
which a HFD inﬂuences the health of the offspring is not clear, disrup-
tion of normal epigenetic regulation is likely involved.
Unfortunately, the precise functional role of the epigenetic changes
related to a HFD exposure in utero and the increase in disease suscepti-
bility is not well understood and requires further investigation. Part of
the issue is limited not simply to practical issues concerning study de-
sign (type of diet, timing, sex) and the confounding effects of genetic
variation (animalmodel and background) but also to the difﬁculty asso-
ciated with interpreting the epigenetic outcomes.
517L. Williams et al. / Biochimica et Biophysica Acta 1842 (2014) 507–519Epigenetic modiﬁcations associated thus far with in utero program-
ming associated with a maternal HFD include DNA methylation and
histone modiﬁcations. Other epigenetic changes, such as chromatin
structural patterns, gene expression changes controlled by RNAi,
hydroxymethylation [100], or O-linked N-acetylglucosamine transfer-
ase changes [101–103], although central to the topic of epigenetics,
have not been studied widely in the context of HFD exposure and
DOHaD. Thus, future studies aimed at elucidating involvement of
these processes in the context ofmetabolic disease pathogenesis associ-
ated with early life exposure to HFD may shed new light on molecular
mechanisms underlying this epidemic.
Although these animal models have extended our knowledge of the
epigenetic mechanisms associated with metabolic disease, particularly
DNA methylation changes, several questions still remain. One such
question is whether additional pathologies linked to a HFD in utero
can be correlated with epigenetic changes other than DNA methylation
andwhat animalmodel is best suited to studies on fetal programmingof
adult disease. It also remains to be determined whether similar out-
comes are encountered in human populations. If so, dietary changes
during a critical period of development should be identiﬁed with the
aim to develop future guidelines for a healthy pregnancy. Meanwhile,
the growing body of knowledge derived from animal models suggests
cautionary measures should be taken regarding dietary habits during
pregnancy andpostnatal development tominimize offspring risk for en-
hanced susceptibility to develop metabolic disease as adults.
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